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Resumo 
 
 
A resistência bacteriana é um ponto importante de estudo em investigação 
relacionado com o ambiente e a saúde pública, devido à ineficiência dos 
antibióticos, que resulta de uma subpopulação de células bacterianas que 
entram num chamado estado dormente. Diversos estudos indicam que os 
sistemas toxina-antitoxina estão envolvidos nessa persistência bacteriana. Um 
exemplo de um sistema toxina-antitoxina é o complexo HipAB, em que a HipA 
e a sua respetiva antitoxina estão intimamente relacionadas. HipB é muito 
instável e propenso à degradação por proteases (por exemplo: Lon protease), 
deixando a HipA a exercer o seu efeito tóxico nas células, Para estudar as 
conformações e interações da HipAB na Shewanella oneidensis, foi necessário 
sob expressar e purificar as proteínas e promover as reações de cross linking 
que foram analisadas por espectrometria de massa. A reações de cross linking 
foram realizadas usando o BS3 (Bis[sulfosuccinimidyl] suberate), um cross 
linker in solution, testado a diferentes concentrações  (0.5mM, 1mM, 2mM) 
para encontrar as condições de reação mais eficientes.  Pelas análises de 
SDS-PAGE foi possível concluir que a melhor concentração de cross linker foi 
a mais alta testada. Para além disso, foram feitas algumas previsões de 
possíveis sítios de ligação, intra- ou intermolecular, no entanto só foi possível 
identificar uma das interações entre a HipA(143) com a HipA(264). 
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Abstract 
 
Bacterial resistance is a major issue in research related to environmental and 
public health, due to the ineffectiveness of antibiotics, resulting from a 
subpopulation of bacterial cells entering a dormant state. Multiple studies 
revealed that toxin-antitoxin systems are involved in such bacterial persistence. 
An example of such a toxin-antitoxin system is the HipAB complex, where 
HipA, and its cognate antitoxin are intimately related. HipB is very unstable and 
it is prone to degradation by proteases (e.g. Lon protease), leaving HipA 
exerting its toxic effect on cells. To study the conformations and interactions 
from HipAB in Shewanella oneidensis, it was necessary to overexpress and 
purify the proteins and to perform cross linking reactions which were analysed 
by mass spectrometry. The cross linking reactions were performed with BS3 
(Bis[sulfosuccinimidyl] suberate), an in solution cross linker, tested at different 
concentrations (0.5mM, 1mM, 2mM) to find more efficient reaction conditions. 
By SDS-PAGE analysis it was possible to conclude that the best cross linker 
concentration is the highest tested. Furthermore, some predictions from 
possible intra- and intermolecular binding sites were made, unfortunately it was 
only possible to identify an interaction between HipA(143) and HipA(264). 
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1. Introduction 
Bacterial antibiotic resistance and tolerance play an important role in bacterial survival upon 
antibacterial treatment being a major issue in research related to public health. One mechanism 
by which bacteria defend themselves against antibiotics is a transition towards a dormant state 
called persistence, by which, cellular metabolism and growth are slowed. Recent studies led to 
the concept that toxin-antitoxin (TA) complexes are one of the systems involved in the 
regulation of bacterial persistence (Schumacher et al., 2009). In Escherichia coli, a HipA gene 
encodes a toxin protein of approximately 433 amino acid residues (Schumacher et al., 2009). 
HipA is a high persistence toxin that is neutralized by its cognate antitoxin, HipB. Release of HipB 
leads to activation of HipA that negatively regulates protein translation. Curiously, during a 
transposon mutagenesis screen for proteins involved in biofilm formation, a HipA homologue in 
the metal reducing organism Shewanella oneidensis MR-1 was observed (Theunissen et al., 
2010). This study aimed to analyse the interactions of this HipA homologue with its antitoxin 
and make a structural comparison with the E. coli complex.   
 
1.1. Biofilms formation in bacterial persistence  
In their natural environment the majority of bacteria exist as a complex and organized 
ecosystem, called biofilm, rather than as individual planktonic cells. Biofilms are formed when 
bacterial cells attach themselves to a biotic or abiotic surface (Costerton et al., 1999). The 
bacterial cells have specific mechanisms to attach to a surface, and to develop the biofilm 
structure, as well for decoupling from the biofilm. It is suggested that biofilm is a single entity 
that has control over the individual member to yield the activities that are necessary for colony 
survival (Wolcott et al., 2008).  
A biofilm has a “mushroom-like” shape that usually consists of several microcolonies of cells 
which are separated from each other by a network of water channels (Stoodley et al., 2002). 
The water channels allow the uptake of nutrients and the removal of metabolites, but are also 
used for intercellular communication by means of signalling molecules that are secreted. The 
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cells form a matrix and produce an extracellular polymeric substance (EPS) that gives the biofilm 
strength and protection (Stoodley et al., 2002). Therefore, a biofilm is not a homogeneous 
structure and the actual structure will depend on many parameters, such as the microbial 
community composition, the nutrient stock and the physicochemical properties of the 
environment.  
 
1.2. Persister Cells 
Antibiotics play a major role in the treatment of infectious diseases, but their effectiveness is 
highly compromised by the rise of antibacterial resistance. An antibacterial agent can kill 
bacteria by inducing the formation of corrupted products which lead to cell death (Figure 1) 
(Lewis, 2010). However, this can be prevented by antibiotic resistance or tolerance from the 
bacteria to the antibacterial agent. Within a population, particularly in a biofilm, it has been 
demonstrated that a subgroup of cells, called persister cells, tend to survive antibiotic 
treatment. When a bacterial population is treated with a single antibiotic, only regular cells die, 
whereas persisters can survive. Persister cells are not mutant cells but dormant cells that are 
formed stochastically (Yamaguchi et al., 2011). The antibiotic tolerance results from a change in 
sensitivity to elicitors (Ayres and Schneider, 2012), meaning that the antibiotic has no longer 
effect on the cells. Being antibiotic tolerant is quite different from being antibiotic resistant. 
Antibiotic resistance results from a random or stress-related mutation in the bacterial genome 
or it can result from horizontal gene transfer, and is permanent or hereditary, since this change 
occurs at the gene level. When exposed to antibiotics, the mutant bacteria are able to survive.  
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Figure 1 - Antibiotic resistance and antibiotic persistence scheme (image adapted from Lewis, 2010). 
 
This phenomenon is more pronounced in a biofilm environment (Yamaguchi et al., 2011). 
Regular cells within a biofilm are likely to be killed, but the matrix protects the persister cells. 
When the concentration of antibiotic decreases, the persisters repopulate the biofilm (Figure 2).  
 
 
Figure 2 - Biofilm formation on a surface including persister cells and regular cells. High doses of antibiotic applied 
kill the regular cells. The matrix from the biofilm protects the persister cells and cause the relapse of the infection 
(Lewis, 2010). 
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1.3. Toxin-Antitoxin Systems 
The development of persistence is partially controlled by so-called toxin-antitoxin systems. It is 
thought that toxins may promote cellular adaptation by slowing down cell growth, inhibiting or 
leading to cell death as a result of physical and chemical stress (Van Melderen, 2010, Van 
Melderen and De Bast, 2009). A toxin-antitoxin system generally consists of two components: a 
stable toxin and a labile antitoxin (Van Melderen, 2010). The antitoxin can be translated into an 
mRNA or a protein, which is mainly what defines the toxin-antitoxin type systems. The antitoxin 
instability is typically due to the less ordered structure which makes it more susceptible to 
degradation.  
 
1.3.1. Toxin-Antitoxin system Types 
Toxin-antitoxin (TA) systems can be classified into three different types (type I, II and III), 
depending on the antitoxin nature and/or mode of action. Antitoxins can be either RNA 
molecules (type I and III) or proteins (type II). RNA antitoxins interfere with the toxin function by 
forming an RNA-protein complex (Yamaguchi et al., 2011). On the other hand, the protein 
antitoxin interacts with its toxin, neutralizing its toxic effect. Type I and II systems were 
discovered on plasmids in the 80s (Jaffe et al., 1985, Ogura and Hiraga, 1983) and in 
chromosomes in the 90s (Masuda et al., 1993). In this work, we will focus on type II systems. 
Typically, they are organized in an operon that consists of a gene encoding for a small toxin, 
with an approximated size of 400 amino acid residues that is preceded by a gene encoding for 
its antitoxin (Figure 3). 
 
Figure 3 - Typical TA system loci organization, with the antitoxin preceding the toxin, their sizes and distance 
profiling are schematically represented (image from Sevin and Barloy-Hubler, 2007). 
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1.3.1.1. Type II toxin-antitoxin system types 
Type II TA systems have been the most studied systems (Van Melderen, 2010). It is shown that: 
(a) TA systems are organized in operons with the antitoxin gene being upstream of the toxin 
gene, which are usually overlapping by a few bases (Figure 3) (Yamaguchi and Inouye, 2009, 
Sevin and Barloy-Hubler, 2007); (b) the toxin and its antitoxin form a stable TA complex to block 
the function of the toxin; (c) the antitoxin is more labile than the toxin so in order to block the 
toxic effect from the toxin it needs to be continuously produced; (d) antitoxins are degraded by 
stress-induced proteases releasing toxins from the TA complexes in the cell, which leads to 
growth inhibition or cell death (Christensen et al., 2004). The toxin and antitoxin have different 
lifetimes. The toxin is highly resistant to proteases, whereas the antitoxin can be degraded by a 
specific protease belonging to the Lon family of ATP-dependent proteases (Figure 4) (Yamaguchi 
et al., 2011). 
 
Figure 4 - Toxin-antitoxin system scheme. The antitoxin neutralizes the toxin. However, the antitoxin is very labile 
and unstable and can be degraded in the presence of proteases allowing the toxin to have its toxic effect in its 
different cellular targets (image from (Williams and Hergenrother, 2012). 
 
1.3.2. Toxin-Antitoxin systems in chromosomes 
Type II systems are quite common in bacterial chromosomes and are often found in multiple 
copies with the genome (Makarova et al., 2009). Chromosome-encoded TA systems are thought 
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to confer an evolutionary advantage on the bacterial population as they enter in the regulatory 
network of the host cell. There are no systematic studies on how chromosomal TA systems 
appeared however, for type II TA systems is quite clear that they have entered host cells by 
horizontal gene transfer (Pandey and Gerdes, 2005). Latest studies have shown that 
chromosomal type II TA systems have some similarities to the plasmid-encoded TA systems, as 
they can be involved in the stabilization of genomic fragments or in integrative processes of 
conjugative elements (Leplae et al., 2011).  
 
1.3.3. HipAB and persistence in Escherichia coli 
The HipAB operon is constituted of 2 genes, HipB and HipA (Figure 4). HipAB is a typical type II 
TA system. The operon encodes for two proteins with 10kDa and 51kDa, HipB and HipA 
respectively (Schumacher et al., 2009) playing an important role in persistence formation. The 
persistence formation occurs when HipA is overexpressed (Falla and Chopra, 1998). However, 
HipA can be neutralized by HipB, acting as a neutralizer and a transcriptional repressor of HipAB 
operon (Shanbhag et al., 1994). 
The HipA gene is associated to different phenotypes, such as the toxic wild-type HipA and the 
high persistent or cold sensitivity of HipA7. The HipA7 mutant contains a higher frequency 
ability of 10-2 persistent cells when compared to the wild-type. It was shown that HipA7 is 
nontoxic, and that it is the result of a double mutation (G22S and D291A) (Korch et al., 2003). In 
addition, in the absence of HipB, it was shown that HipA7 expression ensures a high persistence 
phenotype, leading to the conclusion that HipB is not essential for this phenotype. Persistence 
and toxicity might, therefore, be independent: the HipA7 mutant seems to be less efficient in 
inhibiting macromolecule synthesis as compared to the wild-type HipA. The HipA7 allele is 
possibly responsible for the tolerance to several antibiotics and other stressful situations (Korch 
et al., 2003, Van Melderen and De Bast, 2009).  
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1.3.3.1. HipB  
Neutralization of the HipA toxin by the HipB antitoxin differs from other TA systems. HipB has 
no known homology with other TA systems antitoxins. Normally, protein antitoxins have a C-
terminal extension which will only bind to its cognate toxin (Hansen et al., 2012). HipB encodes 
for a small DNA-binding protein with a helix-turn-helix DNA-binding motif functioning as a 
regulator of the HipAB operon by binding to a consensus sequence TATCCN8GGATA (being N any 
nucleotide) (Hansen et al., 2012, Korch et al., 2003).  
 
1.3.3.2. HipA 
HipA is a serine/threonine kinase that phosphorylates its targets, being a member of the 
superfamily of phosphatidylinositol 3/4-kinases (Correia et al., 2006, Schumacher et al., 2012, 
Schumacher et al., 2009). E. coli HipA has structural homology with CDK2/cyclin A kinase 
(Schumacher et al., 2009). The structural homology between HipA and CDK2 is highest in the C-
terminal region that contains CDK2 catalytic residues, suggesting that HipA functions as a 
protein kinase, as reported (Correia et al., 2006). A key element in the function of this protein is 
the autophosphorylation of serine 150 by ATP, which plays a major role in the regulatory 
mechanism of HipA (Schumacher et al., 2012). The finding of the autophosphorylation position 
was possible using a mutated HipA in Asp309→Gln309 (D309Q), to compare the ATP binding 
affinity with HipA (Schumacher et al., 2009). Indeed, the D309Q mutation abolishes persistence, 
suggesting that the kinase function of HipA is a key element, resulting in the phosphorylation of 
one or more target proteins. In E. coli, the target of HipA appears to be EF-Tu, the Elongation 
Factor Thermo unstable (Correia et al., 2006).   
 
1.3.3.3. EF-Tu 
HipA acts on the EF-Tu activity by phosphorylation of Thr382. EF-Tu is a prokaryotic elongation 
factor, which, in its non-phosphorylated form, catalyses the formation of a tertiary complex 
with aminoacyl-tRNA and GTP, and is a key mediator in the translation process. EF-Tu belongs to 
the superfamily of guanosine trifosfatases (GTPases) (Van Melderen and De Bast, 2009). EF-Tu is 
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an essential GTP-binding elongation factor that mediates the delivery and entry of charged tRNA 
molecules to the ribosomal A site (Hayes and Van Melderen, 2011). In the Thr382 
phosphorylated state, the GDP-bound conformation favours the elimination of the aminoacyl-
tRNA bound. This bond elimination occurs due to a conformational change to an open form, 
which does not allow the binding to the ribosome obstructing translation (Schumacher et al., 
2009).  
 
1.4. Shewanella oneidensis Metal Reducing 1 
The species Shewanella oneidensis Metal Reducing 1 belongs to the phylum Proteobacteria, 
class γ-Proteobacteria, order Alteromonadales and the family Shewanellaceae. S. oneidensis 
MR-1 stands for "metal reducing", meaning that it can use metals as a terminal electron 
acceptor, a special feature of this bacterium (Bagge et al., 2001). The Shewanellaceae family 
encloses approximately 30 Shewanella species, which can be found in soil and in sediment 
environments; it has also been described as a pathogen in humans and animals (Venkateswaran 
et al., 1999). Shewanella species are gram-negative, capable of surviving and proliferating in 
both aerobic and anaerobic conditions, and exhibit a strong flagellar motility (Theunissen et al., 
2010). This organism has a high ability to spread and form biofilms, which can make it highly 
persistent in the environment. Theunissen et al. (2010) found during a transposon mutagenesis 
screen for proteins involved in biofilm formation a HipA homologue in the metal reducing 
organism S. oneidensis MR-1. HipA (Figure 5) and HipB (Figure 6) show respectively 29.9% and 
20% sequence identity with the E. coli proteins. However, the number of amino acid residues 
differs from E. coli to S. oneidensis, with HipA shorter and HipB longer in S. oneidensis.  
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Figure 5 - Sequence alignment from HipA in E. coli with HipA in S. oneidensis. The signs : and . under the sequences 
note the different amino acids in the sequences, * stands for the same amino acids. 
 
Figure 6 - Sequence alignment from HipB in E. coli with HipB in S. oneidensis MR-1. The signs : and . under the 
sequences note the different amino acids in the sequences, * stands for the same amino acids. 
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Cross-linking studies have shown that, in solution, HipB forms a dimer (Shanbhag et al., 1994). 
As referred before, HipB binds to HipA and is also a DNA-binding protein. Structural studies 
revealed that HipB in its dimer form interacts with DNA through major groove contacts as well 
as with two HipA molecules. HipA-HipB bound to DNA causes it to bend at an angle of 70˚ which 
is induced by HipB (Figure 7). This deflection ensures that the N-terminal region of HipA can 
bind to HipB subunit and that the C-terminal region of HipA is capable of binding to a different 
HipB subunit (Schumacher et al., 2009). HipB makes use of noncontiguous residues to bind to 
HipA well-ordered domains and not to loops. When HipA is bound to HipB it is neutralized and 
cannot exert its toxic effect, by phosphorylating EF-Tu and interrupting translation of proteins. 
HipA’s interaction with HipB happens in normal conditions; however, the toxic effect can be 
activated due to the presence of certain proteases, able to degrade HipB. Therefore, if HipA 
disengages from the DNA-bound tetramer structure it can exert its toxic effect.  
 
 
Figure 7 - HipA-HipB-DNA complex. (A) HipA-HipB-DNA operator complex, two HipA are represented in blue and 
HipB dimer is in yellow and orange, the DNA is represented in sticks (Schumacher et al., 2009). 
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1.5. Experimental approaches 
A typical workflow for the study of proteins and their interactions usually involves several steps, 
beginning with the overexpression of proteins, additional analyses of the proteins’ profile 
through mass spectrometry (MS) followed by the protein purification by chromatographic 
separation (Figure 8). This study made use of three proteins: HipA, HipB and mutant HipA. The 
mutant HipA, Asp306→Gln306 (D306Q) was selected as this abolishes the activity in E. coli, 
allowing to compare the different behaviours from a persistent and non-persistent bacteria. 
 
 
Figure 8 - Workflow used for the analysis of HipA, HipB and HipA (D306Q). 
 
1.5.1. Protein overexpression and purification techniques 
- Immobilized metal affinity chromatography (IMAC) 
Immobilized metal affinity chromatography allows purifying a protein by its affinity to the resin. 
Often, when cloned, proteins are tagged with histidine. Histidine displays a high affinity to 
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metals. Nickel-nitrilotriacetic acid (Ni-NTA) resin has a high affinity to the 6-histidine-tagged 
proteins, allowing the specific purification of His-tagged proteins.  
 
- Size-exclusion Chromatography 
Size-exclusion chromatography (SEC) allows the purification of proteins according to their 
hydrodynamic volume, which is for globular proteins related to their size. The first compounds 
to be eluted are larger molecules. The Superdex 200 is a separation resin based on highly cross-
linked agarose beads covalently to which dextran molecules are bound. The gel filtration 
properties of the Superdex matrix are led mainly by the dextran chains. 
 
1.5.2. LC-MS analysis 
- High Performance Liquid Chromatography (HPLC) 
Liquid chromatography (LC) is a separation technique based on the distribution of the 
components of a mixture between the mobile phase (a flowing liquid) and a stationary phase 
(sorbents packed inside a column). In HPLC, typically the stationary phase consists of silica 
particles of a smaller size than the ones used in medium pressure chromatography, leading to 
increased resolution, but requiring the use of high pressure systems. HPLC is characterised by its 
high capacity, efficiency, selectivity, and resolution and can be easily automated. 
To optimize the separation of different compounds, recent studies often couple LC with 
detection by mass spectrometry.  
 
1.5.2.1. Mass Spectrometry 
Mass spectrometry (MS) was the main method used for the analysis and monitoring the HipA 
and HipB in these studies.  
A mass spectrometer, in general, is based on four main components: a sample injector, an ion 
source, an analyser and a detector (Figure 9); data obtained are processed using an electronic 
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support, with mass spectra as an output. In more detail, in the ion source the molecules of the 
sample are ionized becoming positively or negatively charged. The ions are then separated by its 
mass/charge (m/z) ratio in the analyser and are detected by the detection system.  
In a mass spectrum, the x axis stands for the m/z, value of the ion and in the y axis is the relative 
abundance represented, using the main abundant ion intensity for normalization.  
 
 
Figure 9 - Mass spectrometer components scheme. 
 
In this study the main ion sources used were the electrospray ionization (ESI) and matrix-
assisted laser desorption ionization (MALDI).  
 
1.5.2.2. Ionization sources used in this project 
- Electrospray Ionization (ESI) 
For electrospray ionisation, the sample is solubilised in a solvent, which is normally more polar 
than the analyte. Thereafter, the solution is injected to the source with a needle which is 
inserted in a metallic capillary with a continuous flux. To make the solution flow out of the 
capillary a potential difference is applied, leading to the formation of a Taylor’s cone. From his 
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cone, charged droplets are released containing a number of dissolved analyte molecules. The 
released droplets are dried with a non-charged gas, like nitrogen, which induces solvent 
evaporation and leads to a decrease on particle size (Figure 10). As the particles get smaller, 
they explode due to charge repulsions, originating in smaller droplets. This process occurs 
several times until there is no solvent present in the solution and only the analyte ions remain 
(El-Aneed et al., 2009). ESI has been widely used in the analysis of biomolecules; its great 
success in the analysis of proteins is due to its ability of producing multiple charges allowing the 
analysis of compounds with a higher molecular weight with a standard mass spectrometer.  
 
 
Figure 10 - Schematic representation of ionization by ESI (image from www.magnet.fsu.edu/). 
 
- Matrix-assisted laser desorption ionization (MALDI) 
In MALDI, ions are desorbed from a solid phase. A sample is first dissolved in a suitable solvent 
and afterwards an excessive amount of an appropriate matrix is added to the sample. In this 
study, the matrix used was α-cyano-4-hydroxycinnamic (α-cyano). After on MALDI plate and 
drying, the plate is loaded into the mass spectrometer and irradiated with a laser beam. Energy 
is absorbed by the crystals and dissipated, with the result that protonated or deprotonated 
sample molecules and the matrix pass to the gas phase, resulting mainly in mono-charged 
molecules (Figure 9) (El-Aneed et al., 2009). 
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Figure 11 - Schematic representation of ionization by MALDI (image fromwww.magnet.fsu.edu/). 
 
The ions that are produced are usually analysed by TOF analysers, and more recently by TOF-
TOF geometry allowing tandem mass experiments and providing additional structural 
information, with high resolution and accuracy. 
 
1.5.2.3. Mass Analysers used in this project 
- Linear Ion Trap 
A linear ion trap results from the application of a specific electric field on a quadrupole which 
traps the ions produced by the ionization source. At the end of the quadrupole, a voltage 
gradient is applied so that the ions can leave the ion trap by an increasing m/z value.  
 
- Time of flight (TOF) analyser 
The TOF analyser determines the time that the ions take to reach the detector. Therefore, ions 
are accelerated by an electric field. When the ions are accelerated their velocities are inversely 
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proportional to the square root of their mass, so the lighter ions reach higher speeds and arrive 
at the detector before the ions with higher mass.  
 
- Fourier transform ion cyclotron resonance (FT-ICR) 
The Fourier transform ion cyclotron resonance is based on the determination of the cyclotron 
frequency of the ions in a fixed magnetic field. The ions are injected into the cell perpendicular 
to the magnetic field (Marshall et al., 1998). The applied magnetic field causes the ions to 
oscillate in the z direction of the magnetic field, causing the cyclotron motion. The ion 
movement has a frequency associated to the ion m/z.  It is determined by a set of electrodes 
through which a current is formed by the ion movement in the magnet. The resulting signal is 
called free induction decay (FID), that consists of a superposition of sine waves. Data is 
processed by a Fourier transform enabling to determine the m/z of the ions (Marshall et al., 
1998). Among other mass spectrometry analysers, FT-ICR has the best resolving power and 
mass measurement accuracy (Marshall et al., 1998).   
 
- Tandem mass spectrometry 
Tandem mass spectrometry allows generating a specific ion fragments from the analyte. It 
consists of selecting and isolating a specific m/z value (precursor ion) that is submitted to 
dissociation. Consequently, ion fragments originating from the “parent” ion are produced. In 
order to achieve this specific fragmentation, several analysers are coupled in series, so that the 
ion isolation is performed by the first analyser, followed by fragmentation in the collision cell 
and the fragmented ions are separated based on their m/z value by the last analyser. However, 
some instruments (linear ion trap and FT-ICR) that have only one analyser are also able to 
perform multiple MS (MSn), making these efficient instruments in the structural identification of 
several molecules including peptides. The linear ion trap allows the study of different ion 
fragmentations. It allows to retain the ion fragments to study in the ion trap and doing an MSn 
(with n>2, representing the number of generations of ions to be analysed) denominated tandem 
mass spectrometry (El-Aneed et al., 2009). 
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Tandem mass spectrometry has an increased relevance when it is necessary to know more 
information about the biomolecule under study. Using this technology it is possible to generate 
information about the structure of the molecules. 
 
1.5.3. Protein cross linking techniques 
Different molecules can have different affinities to each other and can establish covalent or 
ionic bonds. There are different cross linkers that can be added to promote the reaction 
between different compounds. When choosing the cross linker it is important to know whether 
the protein is soluble or not and what sort of linking reactions will be promoted. The most 
common cross linkers are DSS (Disuccinimidyl suberate) and BS3 (Bis[sulfosuccinimidyl] 
suberate). The BS3 reacts with primary amino groups (-NH2) to form stable amide bonds 
releasing N-hydroxysuccinimide. HipA and HipB proteins have several primary amine groups in 
the side chain of lysine (K) residues and in the N-terminal of each peptide or protein. A common 
technique used to study cross linking is by LC-MS, where the ionization source is ESI and the 
analyser is a FT-ICR. The cross linker will add to a peptide or protein 158Da, resultant from the 
cross linking reaction. We aimed to use the study of the HipAB interactions using cross linking 
techniques to compare the complex formed in S. oneidensis with the known structure from E. 
coli.  
 
1.5.4. Phosphorylation studies 
In cells, phosphorylation is mainly mediated by ATP (Schumacher et al., 2009). HipA is a toxin 
whose effects depend on its phosphorylation level; it is also responsible for the phosphorylation 
of other molecules, such as EF-Tu, as it was explained in section 1.3.3.3. So it became important 
to understand what happens to phosphorylated and non-phosphorylated HipA. To 
phosphorylate HipA in vitro, similarly to phosphorylation in vivo, ATP and the cofactor Mg2+ 
were added. On the other hand, to obtain the non-phosphorylated HipA in vitro, a phosphatase 
is added to the protein in order to remove all the phosphate groups binding HipA. The 
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availability of phosphorylated and non-phosphorylated HipA are important to study the 
mechanism of persistence and the conformational alterations. 
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2. Aim of the research project 
The overall objective of this study is to understand the difference between structure and 
function of S. oneidensis MR-1 HipA, HipB and HipA(D306Q) compared to the known E. coli TA 
structure. In order to achieve this objective, several specific tasks will be carried out: 
- Overexpression of the three proteins: HipA, HipB and HipA (D306Q).  
- Purification of the overexpressed proteins;  
- Analysis of the protein interactions. In order to study protein interactions, a cross linking 
experiment was performed followed by the analysis by SDS-PAGE, digestion, extraction and  
analysis by LC-MS. The cross linker used, BS3, has an average reaction time of 30 to 45 minutes 
and the aim was to optimize the reaction conditions and to find the ideal final concentration of 
BS3, in order to identify some of the different molecules formed after the cross linking reactions, 
for the phosphorylated and non-phosphorylated HipA, HipB and for the complex HipAB. 
Overall, it is the intention of this study to understand the mechanisms of action of the toxin-
antitoxin system in S. oneidensis.   
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3. Results and discussion 
 
3.1. Protein Overexpression 
A E. coli strain containing a pET15b vector for  overexpression of HipA and HipB was available. 
The cloned genes, HipA and HipB, were fused with an N-terminal His-tag (Figure 12). Due to the 
high affinity of histidine to immobilized metals, such as nickel, the N-terminal His-tag is often 
used for protein affinity purification. For HipA, HipB and HipA(D306Q) protein expression, cells 
were cultured in 1L LB medium supplemented with 250mg/mL carbenicillin and incubated at 37 
°C shaking at 200 rpm until the optical density (O.D.)(λ=600nm) = 0.6 was reached. The 
antibiotic used to select the bacteria was carbenicillin since the vector used contains a 
resistance marker to this antibiotic (Figure 12). During the incubation time the O. D. at 600nm 
was monitored. When the bacterial cells growth was maximum, IPTG was added to induce 
protein overexpression. After the addition of IPTG, an increase in optical density measured at 
600 nm (Friedrich et al., 1995) was observed. 
The ability of IPTG to mimic allolactose makes it important for use in overexpression 
experiments. Allolactose is a disaccharide similar to lactose. Lactose acts as an inducer of the 
Lac operon which will cause the cell to produce β-galactosidase and consume the lactose. After 
the addition of the IPTG, the Lac repressor will not bind anymore to the Lac operon, and the 
RNA polymerase is transcribed. Once the T7 RNA polymerase protein is expressed, it binds to 
the T7 promoter sequence upstream of the gene of interest on the plasmid insert and 
transcribes it (Clark et al. 2012). 3 hours after adding the IPTG, the protein of interest will be 
overexpressed in the cell, therefore it can be extracted for further studies. Expression was 
monitored every 60 minutes by collection of a 1 mL aliquot to be later analyzed by SDS-PAGE. 
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Figure 12 – Schematic representation of the pET-15b vector. The pET-15b vector carries an N-terminal His-Tag 
sequence (362-380) followed by a thrombin site and three cloning sites. Unique sites are shown on the circle map. 
Note that the sequence is numbered by the pBR322 convention, so the T7 e expression region is reversed on the 
circular map. The cloning/expression region of the coding strand transcribed by T7 RNA polymerase is shown 
below. Cb (4643-5500) is referent to the carbenicillin vector resistance gene. Cb is a 
bacteriolytic antibiotic belonging to the carboxypenicillin subgroup of the penicillins (image from 
www.aidsreagent.org/pdfs/pet15b.pdf). 
 
3.1.1. HipA, HipB and HipA(D306Q) overexpression – analysis by SDS-PAGE  
Each sample withdrawn before and after the addiction of IPTG was analyzed by SDS-PAGE 
(Figure 13).  
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Figure 13 - SDS-PAGE showing the overexpression of HipB, HipA and HipA(D306Q). Under each protein name are 
the numbered lanes. Lane 1 represents the aliquot collected before the IPTG addition; lane 2 represents the aliquot 
collected 1h after the IPTG addition; lane 3 represents the aliquot collected 2h after the IPTG addition; lane 4 
represents the aliquot collected 3h after the IPTG addition. The red rectangles highlight the overexpressed protein 
bands selected for MALDI-TOF identification. The bands were subjected to in gel, where the proteins were digested 
and the peptides extracted for analyse. 
 
The bands that indicated (Figure 13) were cut and in gel digestion was performed using trypsin, 
a proteolytic enzyme commonly used. Trypsin cleaves the peptide chain mainly at the carboxyl 
side of the amino acids: lysine (K) and arginine (R), except when either is followed by proline (P). 
Trypsin is a robust enzyme and produces peptides with advantageous properties like length, 
charge and fragmentation behavior. The resulting peptides were analyzed using MALDI-TOF. 
From the MALDI-TOF spectrum (Figure 14), a Mascot database MS search for protein 
identification was performed. Protein identification was based on MS data by matching at least 
five peptide masses and/or MS/MS data, identifying no less than two unique peptides, 
respectively.  
HipB was not detected, most probably due to low concentration. HipB is a relatively small 13 
kDa and unstable protein, which could explain that it was not possible to find the protein 
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neither in the SDS-PAGE nor in the MALDI-TOF analyses. Another possibility to explain the non-
detection of HipB can be due to the detection methods, the Coomassie blue G-250 (~30ng) is 
not sensitive enough to detect the HipB bands. One solution to improve could be to use a more 
sensitive detection method, for example the Silver staining (~5-10ng) this is less compatible with 
the MS analysis. 
 
 
Figure 14 - MALDI-TOF peptide mass fingerprint from a tryptic digest of the 50kDa band displayed in Figure 13, 
HipA samples. The green circles indicate peaks of which the m/z value corresponds to tryptic fragments of HipA. 
 
The 50kDa band corresponds to HipA. There were 13 matched peptides (table 1) which 
corresponds to a protein sequence coverage of 36%. For the mutant HipA(D306Q), 16 peaks 
matched HipA(D306Q) tryptic peptides. As shown in Figure 15, the mutated amino acid appears 
in the peptide with 2356Da. The change from protein HipA wild type to the mutant 
HipA(D306Q), results in an increase of 13Da as expected, since the molecular weight (Mw) of 
the aspartic acid residue is 115.09Da and the Mw of glutamine residue it is 128.13Da. The peak 
resultant from this mutation is highlighted in Figure 15, which is the spectrum referent to the 
HipA(D306Q) sample analysis. 
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Table 1 - HipA matched peptides with the starting and ending position, the observed molecular relative mass (Mr), 
the expected Mr, the calculated Mr and the peptide sequence. The peptide sequence with the amino acid that was 
after mutated is highlighted. 
 
Start – End 
(Peptide 
sequence) 
Observed 
(Mr) 
Expected 
(Mr) 
Calculated 
(Mr) 
Peptide Sequence 
6 – 36 3440.8450 3439.8377 3439.6680 K.TLTLEMHLGDLMIGELSFDATADTFAVHYTK.D 
129 – 145 2102.1235 2100.1163 2099.9808 R.IEDPTMWPMWPMEIWDGKPR.L 
129 – 145 2133.1152 2132.1080 2131.9707 
R.IEDPTMWPMEIWDGKPR.L + 2 Oxidation 
(M) 
179 - 194 2093.2007 2092.1934 2092.0564 K.FEKYHHLVINEFITMR.L + Oxidation (M) 
182 – 194 1672.9846 1671.9773 1671.8555 K.YHHLVINEFITMR.L 
182 – 194 1688.9480 1687.9407 1687.8504 K.YHHLVINEFITMR.L + Oxidation (M) 
198 – 213 1741.0435 1740.0362 1739.9141 K.VLGMNVANVDIVHFGR.Y 
275 – 283 1008.5783 1007.5710 1007.5586 R.LFSLAAKCR.N 
290 – 310 2343.2776 2342.2703 2342.1447 K.QDMLQWALFNLLTGNADAHGK.N 
372 – 380 1043.6876 1042.6803 1042.6135 R.NLLISNLTR.I 
372 - 384 1539.8794 1538.8721 1538.9368 R.NLLISNLTRIARR.I 
284 – 411 3165.8252 3164.8179 3164.6580 R.RIPQAIAEVILMLPPLDEDEASFVAHYK.T 
421 - 429 1097.6497 1096.6424 1096.5553 R.YLGFVDEVR.D 
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Figure 15 - MALDI-TOF peptide mass fingerprint from a tryptic digest of the 50kDa band displayed in Figure 13, 
HipA(D306Q) samples. The green circle indicate peaks of which the m/z value corresponds to tryptic fragments of 
HipA. 
 
3.1.2. HipA, HipB and HipA(D306Q) purification analyses 
In order to understand the mechanism and function of a specific protein, this proteins need to 
be purified. Similarly to studies made with in E. coli (Hansen et al., 2012) TA system, for further 
studies of S. oneidensis TA system, HipA, HipB and HipA(D306Q) were overexpressed and  
purified. As mentioned in section 4.4.1, the proteins for these studies were engineered with a 
His-tag, therefore the immobilized metal affinity chromatography was performed in order to 
separate the His-tagged proteins (Gräslund et al., 2008).  
 
3.1.2.1. HipA purification analyses – IMAC 
The Ni-NTA columns can be used to separate the His-tagged proteins but can also bind proteins 
that contain histidine clusters. In these cases applying a small amount of imidazole during the 
35 
 
purification before applying the imidazole gradient can help to control off-target binding 
(Gräslund et al., 2008).  
 
 
Figure 16 - HipA purification using the Ni-NTA column by IMAC. The protein is eluted when an imidazole gradient is 
applied. The green line represents the concentration of imidazole in the buffer, the blue line represents the sample 
absorption at 280 nm, and the red lines are referent to the collected fractions. 
 
3.1.2.2. HipA purification analyses - SEC 
To complement the IMAC separation, a SEC purification was performed. The SEC purification 
allows a more specific purification since separates mainly by the size of the proteins. The 
purified protein from the IMAC was concentrated to a final volume of 2 mL using Vivaspin 
ultracentrifugation. SEC resolution can increase if the volume of injected protein is smaller, 
being important to concentrate the protein to a smaller volume. If the injection volume is 
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greater than 2mL generally the peak width will be bigger reducing the separation resolution 
(Hong et al., 2012). 
 
 
Figure 17 - HipA purification using the SD200 column by SEC. The protein is eluted at approximately 75mL. The blue 
line is the absorbance at 280nm, the red lines are the collected fractions. 
 
After injection of 2mL of protein, a sharp peak in SEC purification was obtained (Figure 17), 
resulting in a good resolution chromatogram which allows a clear view of the protein from the 
main fractions collected and analyzed by SDS-PAGE. In order to confirm the purity of HipA, an 
SDS-PAGE was performed using the fractions 22-24 (Figure 18), which are corresponding to the 
highest absorbance from the SEC purification.  
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Figure 18 - HipA purification fraction analysis by SDS-PAGE.  
 
3.1.2.3. Generation of phosphorylated HipA (pHipA) 
HipA is a toxin whose effects depend on its phosphorylation level, being also responsible for the 
phosphorylation of other molecules, such as EF-Tu studied in E. coli (Schumacher et al., 2009), 
as explained in section 1.3.3.3. For that reason it became important to study the 
phosphorylated and non-phosphorylated HipA. Similar studies were performed in E. coli, mainly 
to understand the role of autophosphorylation in HipA (Hansen et al., 2012). So, after purifying 
HipA with Ni-NTA, the protein was separated in two aliquots. One aliquot was treated with ATP-
Mg2+ and the other aliquot was used for SEC purification, this allowed us to obtain the 
phosphorylated HipA (Figure 19) and HipA. The addition of ATP-Mg2+ will result in complete 
phosphorylation of HipA (Schumacher et al., 2009). Proteins are biomolecules that differ greatly 
in size from salts and other small molecules, so high molecular substances are excluded from 
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the medium and elute first. The HipA will phosphorylate forming the higher molecular 
substance from the medium and thus eluting first, being separated from other phosphate salts. 
The smaller molecules with lower molecular weight enter the pores from the medium 
Sephadex, eluting later from the Hiprep 26/10 desalting column.  
 
 
Figure 19 - pHipA desalting separation after treatment with ATP and Mg2+ using a Hiprep 26/10 desalting column. 
The blue line is the absorbance at 280nm. 
 
The phosphorylated HipA was used for cross linking studies, to understand the alterations in the 
protein conformation and the protein-protein interactions after cross linking. 
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3.1.2.4. Generation of non-phosphorylated HipA (npHipA) 
One aliquot of pure protein was used to perform the non-phosphorylated studies. In the 
aliquot, phosphatase was added which will cleave any phosphate groups bound to HipA. 
Similarly to the phosphorylated HipA, the non-phosphorylated HipA was also separated with a 
Hiprep 26/10 desalting column, to separate the protein from the phosphate salts and other 
smaller molecules (Figure 20). 
 
 
Figure 20 - npHipA desalting separation after treatment with phosphatase using a Hiprep 26/10 desalting column. 
The blue line is the absorbance at 280nm. 
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3.1.2.5. HipB purification – IMAC and SEC 
 
 
Figure 21 - HipB purification using the Ni-NTA column by the IMAC principles. The protein is eluted when a 
imidazole gradient is applied. The green line represents the concentration of imidazole in the buffer; the blue line 
represents the sample absorption at 280nm. 
 
The HipB protein is more stable as a dimer, having two binding sites, one for HipA and one for 
DNA (Schumacher et al., 2009). However, for the binding to HipA which occurs at the N-
terminal, the His-tag needs to be cleaved. The His-tag can be cleaved with thrombin (Gräslund 
et al., 2008). To study the interactions of HipB as a dimer and as a complex with HipA, after 
IMAC purification thrombin was added and the cleavage was performed overnight. After the 
cleavage HipB was separated by SEC (Figure 22).  
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Figure 22 - HipB purification using the SD200 column by the SEC principles. The protein is eluted around 85mL. The 
blue line is the absorbance at 280nm. 
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3.1.2.6. HipA(D306Q) purification analyses 
 
 
Figure 23 - HipA(D306Q) purification using the Ni-NTA column by IMAC. The protein is eluted when an imidazole 
gradient is applied. The green line represents the concentration of imidazole in the buffer; the blue line represents 
the sample absorption at 280 nm, and the red lines are referent to the collected fractions. 
 
As studied in E. coli the mutant HipA(D309Q) is not high persistent, in contrast to the wild type 
HipA. The HipA and the HipA(D396Q) allow the study and comparison from the ATP binding, 
using isothermal titration calorimetry (ITC) or surface plasmon resonance (SPR) (Schumacher et 
al., 2009). So the same procedures were adopted for HipA(D306Q) purification, was purified by 
SEC (Figure 24). However, further studies were carried on with the HipA(D306Q) by the PhD 
student Yurong Wen. 
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Figure 24 - HipA(D306Q) purification using the SD200 column by SEC. The protein is eluted around 75mL. The blue 
line is the absorbance at 280nm. 
 
3.2. Cross linking studies  
Bis[sulfosuccinimidyl] suberate (BS3) is a homobifunctional N-hydroxysuccinimide ester (NHS 
ester) and is water soluble. BS3 reacts with primary amino groups (-NH2) to form stable amide 
bonds releasing N-hydroxysuccinimide, at a pH range from 7 to 9. HipA and HipB proteins have 
several primary amine groups in the side chain of lysine (K) residues and in the N-terminal of 
each peptide. The BS3 cross linker has to be prepared immediately before use and is soluble only 
up to 100mM.  
In E. coli the main studies focused in the study and characterization of HipA, HipB and its 
interaction, no further studies as cross linking studies are known for HipAB. However, structural 
analysis helped to understand how HipA interacts with HipB, in E. coli, which was then found 
out recently to be similar in S. oneidensis by Yurong Wen. Another major finding in E. coli 
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studies is the autophosphorylation of HipA which was also carried on by PhD Yurong Wen in S. 
oneidensis, being again similar.   
Cross linking studies were performed to further find out which were the interactions between 
proteins, the phosphorylated and non-phosphorylated, HipA and HipB. Validation experiments 
were performed to understand which was the best cross linker concentration. 
 
 
Figure 25 - SDS-PAGE showing the four controls of HipB, HipAB, pHipA and npHipA.  
 
Analysing the SDS-PAGE control gel (Figure 25) shows that the 50kDa bands corresponding to 
HipA, a 51kDa protein. However, as previously explained in section 3.1.1, HipB is difficult to find 
in SDS-PAGE analysis and again was not found. Therefore, for further studies a MS analysis 
should be performed to allow to detect the presence of certain proteins.  
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Figure 26 - SDS-PAGE showing the cross linking reactions of HipB and HipAB. Under each protein name are the 
cross linker, BS3, concentrations used. The bands numbered S1-S4 were further analysed by MS. 
 
We performed a cross linking experiment with HipB. However, analysis of the SDS-PAGE pattern 
(Figure 26) did not allow to conclude about HipB multimerization. This lack of reaction can be 
related with the small size of the protein without the His-tag, around 10kDa or the used 
protease inhibitor may not be efficient in HipB case. The protease inhibitor may be critical to 
maintaining yield, structure and function.  
The HipAB cross linking reaction, using different BS3 concentrations, different products could be 
observed (Figure 26). The more HipA that reacts, the more effective the cross linker will be, 
leading to the conclusion that the 2mM cross linker is more efficient that the other two cross 
linker concentrations, 0.5mM and 1mM. 
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Figure 27 - SDS-PAGE showing the cross linking reactions of HipB and HipAB. Under each protein name are the 
cross linker, BS3, concentrations used. The cut bands are numbered S5-S15. 
 
The HipA and HipB have 24 and 7 lysine residues, respectively.  The cross link reactions the 
bounding between the lysine residues, intermolecular or intramolecular. Where the cross linker 
binds there will be an increase of 158Da. There were some predictions carried using PyMOL, to 
analyse some possible cross linked insights on HipB (Figure 28), HipA (Figure 29) and HipAB 
(Figure 30).  
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Figure 28 - HipB dimer with some predicted intramolecular cross linking bonds. Dashed black lines indicate the 
calculated distance (Ȧ) between the two Cα Lysines. 
 
Within HipB 7 predicted binding Lysines are at a distance smaller than 30Ȧ, so it is possible that 
the cross linking reaction occurs, since the calculated distances range from 6.1-22.6Ȧ. 
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Figure 29 - HipA with some predicted intramolecular cross linking bonds. Dashed black lines indicate the calculated 
distance (Ȧ) between the two Cα Lysines. The black dashed line refers to one predicted bond which has fewer 
possibilities to occur because it is bigger than 30Ȧ, the maximum distance to have a bond between different Cα 
Lysine residues. 
 
Within HipA 3 predicted binding Lysines are at a distance smaller than 30Ȧ, so it is possible that 
the cross linking reaction occurs, since the calculated distances range from 12.4-30Ȧ.  
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Figure 30 - HipA with some predicted intramolecular cross linking bonds. Dashed black lines indicate the calculated 
distance (Ȧ) between the two Cα Lysines. The black dashed line refers to one predicted bond which has fewer 
possibilities to occur because it is bigger than 30Ȧ, the maximum distance to have a bond between different Cα 
Lysine residues. 
 
Within HipAB 5 predicted binding Lysines are at a distance smaller than 30Ȧ, so it is possible 
that the cross linking reaction occurs, since the calculated distances range from 20.6-28.9Ȧ.  
The SDS-PAGE pattern (Figures 26 and 27) shows some evidence for cross linking reactions from 
the HipAB, pHipA and npHipA bands. We observed that the band corresponding to HipA was still 
present. However, as the cross linker concentration was increasing these bands became less 
intense, leading to the conclusion that the higher cross linker concentration allows efficient 
cross linking. There was a strong evidence of cross linking in the different samples, as 
determined by the SDS-PAGE analysis. After the in gel digestion and LC-MS analysis it was 
possible to detect evidence of toxin-antitoxin in the samples as well as other proteins. However, 
in some bands we observed some E. coli proteins, indicating that the proteins purifications were 
not complete. 
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3.2.1. pLink Search 
To understand which intermolecular and intramolecular interactions exist in the proteins, 
pHipA, npHipA and HipAB, we used software package for data analysis of cross linked proteins 
coupled with mass-spectrometry analysis, pLink. pLink is a software that uses MS/MS data and 
the protein sequences as input (table 2) and outputs the spectra with the best score (Figure 31), 
identifying the cross linked peptides as well as the peptides with the cross linker. pLink is 
associated with a pBuild software which gives the report identification. In the report 
identification it is specified which is the proteins interact and which are the lysine positions.  
 
Table 2 – Proteins identified by Mascot Daemon search in NCBI databases. pLink input information was the name of 
the protein and FASTA sequence. Table describes which is the organism referent to each protein and in which 
samples the protein was present (Figures 25 and 26). 
Protein Organism Sample Bands FASTA Sequence 
HipA 
Shewanella 
oneidensis 
S1, S2, S3,S4, S5, 
S13, S14,S15 
MSTAKTLTLEMHLGDLMIGELSFDATADTFAVHYTKDWQQSGFPLSPT
IPLDGTGTSNQISMFLVLLPENKGLDYLIESLGVSKGNTFALIRAIGLDTA
GAIAFVPKGALLPETQLRPIKAEEVIQRIEDPTMWPMEIWDGKPRLSVA
GVQPKLNLFYNGKEFAFAEGTLSSTHIVKFEKYHHLVINEFITMRLAKVL
GMNVANVDIVHFGRYKALCVERFDRRNIPGEQRVLRRHIVDSCQALGF
SVSKKYERNFGTGRDVKDIREGVSFNRLFSLAAKCRNPVAAKQDMLQ
WALFNLLTGNADAHGKNYSFFMTPSGMEPTPWYDLVSVDMYEDFEQ
QLAMAIDDEFDPNSIYAYQLAAFMDGLGLPRNLLISNLTRIARRIPQAIA
EVILMLPPLDEDEASFVAHYKTQLLARCERYLGFVDEVRDVEV 
HipB 
Shewanella 
oneidensis 
S1, S2, S3,S4 
MNGTDIKAKVYEDTLLETIMASPLNQQSLGLLIKERRKSAALTQDVAAM
LCGVTKKTLIRVEKGEDVYISTVFKILDGLGIDIVSAQTSDTETNGWY 
Galactitol-1-
phosphate 
dehydrogenase 
Escherichia 
coli 
S5 
MKSVVNDTDGIVRVAESVIPEIKHQDEVRVKIASSGLCGSDLPRIFKNGA
HYYPITLGHEFSGYIDAVGSGVDDLHPGDAVACVPLLPCFTCPECLKGFY
SQCAKYDFIGSRRDGGFAEYIVVKRKNVFALPTDMPIEDGAFIEPITVGL
HAFHLAQGCENKNVIIIGAGTIGLLAIQCAVALGAKSVTAIDISSEKLALA
KSFGAMQTFNSSEMSAPQMQSVLRELRFNQLILETAGVPQTVELAVEI
AGPHAQLALVGTLHQDLHLTSATFGKILRKELTVIGSWMNYSSPWPGQ
EWETASRLLTERKLSLEPLIAHRGSFESFAQAVRDIARNAMPGKVLLIP 
Trehalose-6-
phosphate 
Escherichia S6, S8, S11, S12 
MTNLPHWWQNGVIYQIYPKSFQDTTGSGTGDLRGVIQRLDYLHKLGV
DAIWLTPFYISPQVDNGYDVANYTAIDPIYGTLDDFDELVTQAKSRGIRII
LDMVFNHTSTQHAWFREALNKESPYRQFYIWRDGEPETPPNNWRSK
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hydrolase coli FGGSAWRWHAESEQYYLHLFAPEQADLNWENPAVRAELKKVCEFWA
DRGVDGLRLDVVNLISKDPRFPEDLDGDGRRFYTDGPRAHEFLHEMN
RDVFTPRGLMTVGEMSSTSLEHCQRYAALTGSELSMTFNFHHLKVDYP
GGEKWTLAKPDFVALKTLFRHWQQGMHNVAWNALFWCNHDQPRI
VSRFGDEGEYRVPAAKMLAMVLHGMQGTPYIYQGEEIGMTNPHFTRI
TDYRDVESLNMFAELRNDGRDANELLAILASKSRDNSRTPMQWSNGD
NAGFTAGEPWIGLGDNYQQINVEAALADDSSVFYTYQKLIALRKQEAIL
TWGNYQDLLPNSPVLWCYRREWKGQTLLVIANLSREIQPWQPGQMR
GNWQLVMHNYEEASPQPCAMTLRPFEAVWWLQK 
Thioredoxin 
Escherichia 
coli 
S6, S11, S15 
MSDKIIHLTDDSFDTDVLKADGAILVDFWAEWCGPCKMIAPILDEIADE
YQGKLTVAKLNIDQNPGTAPKYGIRGIPTLLLFKNGEVASATKVGALSKG
QLKEFLDANLA 
Glutamyl-tRNA 
synthase 
Escherichia 
coli 
S9, S13 
MKIKTRFAPSPTGYLHVGGARTALYSWLFARNHGGEFVLRIEDTDLERS
TPEAIEAIMDGMNWLSLEWDEGPYFQTKRFDRYNAVIDQMLEEGTAY
KCYCSKERLEALREEQMAKGEKPRYDGRCRHSHEHHADDEPCVVRFA
NPQEGSVVFDDQIRGPIEFSNQELDDLIIRRTDGSPTYNFCVVVDDWD
MEITHVIRGEDHINNTPRQINILKALKAPVPVYAHVSMINGDDGKKLSK
RHGAVSVMQYRDDGYLPEALLNYLVRLGWSHGDQEIFTREEMIKYFTL
NAVSKSASAFNTDKLLWLNHHYINALPPEYVATHLQWHIEQENIDTRN
GPQLADLVKLLGERCKTLKEMAQSCRYFYEDFAEFDADAAKKHLRPVA
RQPLEVVRDKLAAITDWTAENVHHAIQATADELEVGMGKVGMPLRV
AVTGAGQSPALDVTVHAIGKTRSIERINKALAFIAERENQQ 
GTP-
cyclohydrogena
se-1 
Escherichia 
coli 
S7 
MPSLSKEAALVHEALVARGLETPLRPPVHEMDNETRKSLIAGHMTEIM
QLLNLDLADDSLMETPHRIAKMYVDEIFSGLDYANFPKITLIENKMKVD
EMVTVRDITLTSTCEHHFVTIDGKATVAYIPKDSVIGLSKINRIVQFFAQR
PQVQERLTQQILIALQTLLGTNNVAVSIDAVHYCVKARGIRDATSATTTT
SLGGLFKSSQNTRHEFLRAVRHHN 
FKBP 
Escherichia 
coli 
S10 
MKVAKDLVVSLAYQVRTEDGVLVDESPVSAPLDYLHGHGSLISGLETAL
EGHEVGDKFDVAVGANDAYGQYDENLVQRVPKDVFMGVDELQVGM
RFLAETDQGPVPVEITAVEDDHVVVDGNHMLAGQNLKFNVEVVAIRE
ATEEELAHGHVHGAHDHHHDHDHDGCCGGHGHDHGHEHGGEGCC
GGKGNGGCGCH 
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Figure 31 - Spectra labeling output resulting from pLink search. Different MS/MS comparisons which resulted in this 
spectrum. Different peptides (Y, B) cross linked (x) or with the cross linker (s). 
 
The pLink search was followed by a spectrum labelling (Figure 31) and an identification report 
(table 3) which allows to conclude about the protein and the lysine residue that cross linked.  
 
Table 3 - Cross linked positions of each sample with the score and binding proteins with lysine positions. 
 
Samples Score Proteins (positions) 
S1 1.27e-002 HipA(143) – HipA(264) 
S5 9.74e-001 Glutamyl-tRNA synthase(1) – FKBP(1) 
S6 8.95e-001 HipA(281) – FKBP(1) 
S7 2.30e-001 Trehalose-6-phosphate hydrolase(144) – HipA(252) 
S7 7.94e-001 Glutamyl-tRNA synthase(352) – Thioredoxin(1) 
S8 4.31e-001 Galactitol-1-phosphate dehydrogenase(2) – Thioredoxin(1) 
S10 8.63e-001 HipA(264) – Glutamyl-tRNA synthase(378) 
S14 1.46e-001 Glutamyl-tRNA synthase(4) – Glutamyl-tRNA synthase(352) 
S14 1.93e-001 HipA(281) – FKBP(1) 
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The identification report from S1 had a score of 1.27e-002 that is relatively high, meaning the 
analysed peptides were significantly with that cross linked positions. S1 compared with the 
other samples, S5, S6, S7, S8, S10, S14, being the probability of cross linking reduced, which is 
indicating possible false positives.    
Therefore, was just possible to identify one intramolecular binding from HipA(143) and 
HipA(264) shown in Figure 32. 
 
 
Figure 32 - HipA with one intramolecular cross linking bond. Dashed white line with the value that is the calculated 
distance (Ȧ) between the two Cα Lysines.  
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4. Conclusion 
The HipAB complex is deeply studied in E. coli, but little is known of its structure and function in 
S. oneidensis. Both bacteria are good models to study the phenomenon of persistence, being 
the subject of on-going research.  In this study, the main aim was to analyse and study protein 
interactions, overcoming the technical limitations. To better understand this aim some 
predictions of conformational alterations were made to give a better overview of the different 
interactions, stressing that may be due to those alterations that the main functions of the 
proteins are altered.  
Mimicking what happens in bacterial cells, cross linking reactions were performed, using BS3 an 
in solution cross linker. BS3 can be used in different concentrations, being more or less efficient 
in cross linking, therefore three different concentrations were used 0.5mM, 1mM and 2mM. 
After the data analysis we concluded that the better cross linking efficiency was obtained with a 
higher concentration. Furthermore, analysis of the cross linking reactions, with LC-MS followed 
by Mascot Daemon research using NCBI database, allowed to confirm the presence of the HipA 
and HipB in the different samples. However for better results some improvements are 
suggested avoiding the increase of temperature to denature the sample for SDS-PAGE, larger 
volume injection in the LC-MS study, to have a larger response for MS analysis. In addition, LC-
MS data was used for analysis with pLink. This allows to identify where the cross linking 
reactions happen (which protein, which lysine residue). After identification of the lysine residue 
involved in cross linking, it is possible to calculate the distance between the bonds, using 
PyMOL. Therefore, this analysis allowed to confirm the bond from HipA(143) with HipA(264) 
with a distance of 17.8Ȧ.  
For further studies, my suggestion is to repeat the protocol with the improvements and 
additionally apply using native mass spectrometry, which can give a better overview from the 
complexes resulting from the cross linking reactions. 
  
55 
 
5. Materials and Methods 
5.1. Chemicals  
The following reagents were obtained from Sigma-Aldrich: carbenicillin (Cb), disodium 
phosphate, sodium chloride, imidazole, HEPES, isopropyl β-D-1-thiogalactopyranoside (IPTG) 
and glycerol. The reagents for SDS-PAGE (SDS, APS, TEMED) were obtained: from Bio-RAD. All 
the solvents used were obtained from VWR and were HPLC grade. All solutions were prepared 
and filtered using ultra-purified water (Millipore) from Milli-Q system. 
 
5.2. Instrumental 
MALDI-TOF analyses were carried out on a 4800 Plus MALDI-TOF analyser (AB SCIEX). SDS-PAGE 
analyses were performed using a Mini-Protean 3 cell electrophoresis system from Bio-Rad. 
Protein purification was carried out on an AKTA Purifier (GE Healthcare). A nickel-nitrilotriacetic 
acid (Ni-NTA) superflow cartridge from Qiagen and a Superdex 200 10/300 GL column (GE 
Healthcare) were used.  
For His-tagged protein purification, the Ni-NTA column was used due to its characteristics: 
deliver of high yields of high-purity protein, up to 50mg/mL and its high stability, which means 
that they are compatible with a wide range of buffer components, including strong denaturants, 
detergents and reducing agents. The affinity of Ni2+ ions is independent on the protein structure 
(native or denatured) (http://www.qiagen.com/Products/Catalog/Sample-
Technologies/Protein-Sample-Technologies/Purification-Kits-and-Resins/Ni-NTA-Superflow-
Cartridges#orderinginformation, 2013).  
The SD200 column is a high performance gel filtration column. This is a pre-packed glass column 
intended for use in gel filtration of proteins, peptides and other biomolecules according to size. 
The gel matrix is composed of Superdex, which is based on highly cross-linked agarose beads 
covalently bonded to dextran molecules. The gel filtration properties of the superdex matrix are 
governed mainly by the dextran chains. The SD200 10/300 GL column has a mean bead size of 
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13 µm and the fractionation range for the globular proteins is 3 000 – 600 000 Da 
(http://www.gelifesciences.com/webapp/wcs/stores/servlet/catalog/pt/GELifeSciences/produc
ts/AlternativeProductStructure_17414/17517501, 2012).  
 
5.3. Software 
MALDI-TOF samples were analysed using the 4000 Series Explorer software with available 
databases tools (Mascot from Matrix Science). The Mascot database software package makes 
the search in the NCBI database. Another software package used was pLink, a programme which 
allows the study of the cross linking positions with resource to MS/MS and protein sequence 
data. 
 
5.4. Methods 
5.4.1. Expression of HipA/HipB 
Each gene (HipA, HipB and HipA(D306Q)) was cloned into BamHI and NdeI cloning sites of 
pET15b vector and fused with an N-terminal His-tag. The vector was then introduced into E. coli 
C43 (DE3) competent cells, by electroporation. Cells were cultured in 1% LB (Lysogeny Broth) 
medium supplemented with carbenicillin 0.04% (v/v) and incubated at 37ºC for 3h at 200rpm. 
At the optical density (O. D.) at 600nm for HipA (and the mutant HipA(D306Q)) and HipB was 0.7 
and 0.6 respectively. When the O. D. 0.7 and 0.6 was reached, isopropyl β-D-1-
thiogalactopyranoside (final concentration 1mM, IPTG) was added and the culture was allowed 
to grow for 3 hours at 37ºC. The culture was centrifuged at 10 000rpm for 5 minutes at 4°C 
(Beckman Coulter Avanti J30 I centrifuge). The supernatant generated was discarded and the 
pellet was either stored at -20°C or used for purification. 
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5.4.1.1. Protein Overexpression 
For evaluation of HipA and HipB overexpression, the O.D. was measured as described above and 
1mM IPTG was added to the samples. In order to control the growth of the bacterial cells, 1mL 
of sample was taken and the O.D. measured every 60 minutes for the following 3 hours. 
Samples (1mL) were centrifuged at 25 000rpm for 7 minutes at 4°C using a Beckman Coulter 
Avanti J30 I centrifuge. The supernatant was discarded and the protein pellet was resuspended 
in ultra-pure water and analysed by SDS-PAGE. Overexpressed protein bands were cut and 
digested overnight with 0.1µg/µL trypsin. The samples were then analysed by mass 
spectrometry (MALDI-TOF). 
 
5.4.1.1.1. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)  
SDS-Page was performed according to instructions of the manufacturer (www.bio-rad.com, 
2000). Bellow a detailed description of the procedure is made.  
 
1. Resolving gel  
A 15% (w/v) polyacrylamide gel was prepared using 10mL Tris-HCl pH 8.8, 10mL ProtoGel 30% 
(w/v) acrylamide/methylene bisacrylamide solution (37.5:1 ratio), 100μL 20% SDS and 10μL 
N,N,N′N′-tetramethylethylene diamine (TEMED) made up to 15mL with double distillated water 
(ddH2O). The polymerization was initiated by the addition of 200μL 0.1mg/mL ammonium 
persulphate (APS). The solution was gently poured into the space between the two glass plates 
to about 3cm from the top of the short glass plate. To ensure a uniform interface between the 
stacking and resolving gels, about 1mL ddH2O was gently overlaid on top and set for 1 hour at 
room temperature. 
 
2. Stacking gel  
A 6% (w/v) polyacrylamide gel was prepared using 676μL 1M Tris-HCl pH 6.8, 867μL ProtoGel 
30% (w/v) acrylamide/methylene bisacrylamide solution (37.5:1 ratio), 75µL 20% SDS, 7.5μL 
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N,N,N′N′-tetramethylethylene diamine (TEMED) made up to 10.5mL with ddH2O. The 
polymerization was initiated by the addition of 150μL 0.1mg/mL APS.  
The stacking gel was immediately added on top of the resolving gel and the appropriate comb 
(10 wells; 5mm x 1mm or 15 wells; 3 mm x 1mm) positioned. The stacking gel was allowed to 
polymerize for 30 min.  
After polymerization, the gel plates were removed from the cast and fitted in the cassette. The 
gel cassette was introduced into the buffer reservoir tank, and the tank was filled with electrode 
buffer [25mM Tris-HCl, pH 8.2, 250mM glycine and 0.1% (w/v) SDS] to cover the cassette. 
 
3. Sample preparation  
For preparation of protein samples, 10μL 6x SDS-PAGE loading dye buffer (360mM Tris-HCl, pH 
6.8, 60% (v/v) glycerol, 12% (w/v) SDS and 0.06% (w/v) bromophenol blue) and 1μL 1M DTT 
were made up to 30μL with ddH2O. The mixture was then heated for 5 minutes at 95°C and 
further centrifuged at 14,000g for 15s to collect any condensed vapour and to sediment any 
insoluble materials. 
 
4. SDS-PAGE electrophoresis  
The gel was electrophoresed at 130volts. Once the bromophenol blue dye front reached the 
bottom of the gel, the run was stopped and the gel was stained with Coomassie Brilliant Blue 
G250 overnight and destained with 30% methanol. 
 
5.4.1.1.2. In-gel digestion and peptides extraction for MALDI-TOF analyses 
1. Destaining of the gel 
After destaining the gel, the bands with the corresponding molecular weight of HipA (and the 
muntant HipA(D306Q)) and HipB were cut from the gel and placed into a 1.5mL vial in small 
slices. The gel pieces were washed with 150µL of 50% ACN/200mM ammonium bicarbonate to 
each vial and incubated for 20min at 30ºC. The gel bands were vortexed and centrifuged at 14 
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000 rpm for 3 minutes, 4ºC (Eppendorf centrifuge 5415R), to remove unpolymerized acrylamide 
and remaining Coomassie. The destaining procedure was performed two more times with 120µL 
and 100µL of 50% ACN/200mM ammonium bicarbonate solution as described above. The 
destained gel pieces were dried in a speedvac for 10 minutes. 
 
2. In-gel Digestion 
In-gel gel digestion was performed by adding trypsin in 50mM ammonia bicarbonate, to each 
sample (0.002µg/µL final concentration). Reaction was kept on ice for 45 minutes, to allow the 
gel pieces to rehydrate. Forty µL of 50mM ammonium bicarbonate were added to each piece 
and the bands were incubated overnight at a 37ºC. 
 
3. Extraction of Peptides 
The digested gel bands were centrifuged at 14 000rpm, 4ºC for 30 seconds (Eppendorf 
centrifuge 5415R), and the supernatants transferred to new 0.5mL vials. Peptides were 
extracted by adding 40µL of 60% ACN/0.1% HCOOH to each gel piece and incubated at 30ºC for 
20 minutes. The samples were then agitated in a vortex for 3 minutes, centrifuged and 
combined with the supernatant to the corresponding 0.5mL vial. The extraction step was 
repeated once, by adding 20µL of 60% ACN/0.1%HCOOH. The peptide solution in the 0.5mL vial 
was dried in a speedvac for approximately 6 hours.  
 
4. MALDI-TOF sample and matrix preparation 
The dried peptides were dissolved in 10µL of 0.1% HCOOH and 0.8µL of this solution were 
spotted on the MALDI-TOF plate. The plate was allowed to dry for a few minutes. The matrix 
was prepared by dissolving α-cyano-4-hydroxycinnamic acid in 50% ACN, 0.1% TFA (5mg/mL). 
The matrix (0.8 µL) was spotted on the plate on top of the spotted peptides and allowed to dry. 
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α-cyano-4-hydroxycinnamic acid matrix was chosen for analysing this proteins and peptides, 
because it is particularly good for molecules smaller than 10kDa.  
 
5.4.1.2. Purification of HipA/HipB 
The protein pellet, from the point 1.4.1., was thawed and resuspended in buffer (25mM 
Na2HPO4, 500mM NaCl), with a free EDTA using a ratio of 1g pellet/25mL extraction buffer. For 
purification, the cell walls were lysed mechanically using sonication. During sonication, high 
intensity ultrasound is used to break the cell walls and release the soluble cytosolic recombinant 
protein. The protein suspension was sonicated for 4 minutes with amplitude of 20%, in a cycle 
of 1 second pulse, and 1 second break, using a Branson 200 and 400 watt sonicator. The lysate 
was centrifuged at 25 000 rpm for 30 min at 4 °C (Beckman Coulter Avanti J30 I centrifuge). The 
supernatant, containing the target protein, was filtered (0.22µL membrane filters) and purified.  
The affinity chromatography is based on IMAC using a Ni-NTA resin. The resin was equilibrated 
in 25mM Na2HPO4, 500mM NaCl, pH of 7.5. The sample was injected into the column and eluted 
with a gradient of 0-100% of 500mM imidazole in equilibration buffer (pH 7.5) was used. The 
imidazole competes with the metal from the resin allowing the protein to be eluted from the 
column. After having the protein separated by affinity, size-exclusion chromatography was 
performed. In order to use HipB for the cross linking experiments it was necessary to cleave the 
His-tag terminal with thrombin, overnight (Zhu et al., 2010). After the cleavage overnight from 
the His-tag, HipB was separated a second time by IMAC to have the purified protein.  
Size-exclusion chromatography was carried out with a Superdex 200 (GE Healthcare) resin. The 
buffer used was 10mM HEPES, 300mM NaCl, 5% glycerol at pH 7.5. A concentrated sample from 
the previous purification (2mL) was applied to the column and eluted with 10mM HEPES, 50mM 
NaCl at a pH of 7.5. The HipA is 51kDa and HipB is 10kDa, so the predicted elution volume of 
these proteins were determined based on the elution volumes of a calibration kit on HiLoad 
16/60 Superdex 200 pg column (Figure 12 and table 1). 
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Figure 33 - Elution profile of the protein calibration kit on HiLoad 16/600 Superdex 200 pg 
column. Elution volumes were determined at peak maximum height (Healthcare, 2006). 
 
Table 4 - The content of Gel Filtration Calibration kit LMW (low molecular weight) (Healthcare, 
2006). 
Protein 
Molecular weight 
(kDa) 
Aprotinin  6500 
Ribonuclease A  13 700 
Carbonic anhydrase  29 000 
Ovalbumin  44 000 
Conalbumin  75 000 
 
By comparing the molecular weight and the elution volume it was possible to determine that, at 
the conditions used, HipA had an elution volume of approximated 80mL and HipB of 
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approximated 100mL. After purification an SDS-PAGE analysis was performed to see the purified 
proteins. 
 
5.4.1.3. Phosphorylation studies 
5.4.1.3.1. Phosphorylated HipA 
The phosphorylation studies were carried out using the purified HipA protein. HipA was 
autophosphorylated overnight with a final concentration of 1mM ATP, pH 7.5. The HipA 
phosphorylates forming a higher molecular molecule from the medium and smaller molecules 
with lower molecular weight which are separated by Hiprep 26/10 desalting column, where the 
small molecules enter the pores from the medium Sephadex, eluting later from the thus eluting 
first the phosphorylated HipA.  
 
5.4.1.3.2. Non-phosphorylated HipA 
The non-phosphorylated HipA was obtained by treating the HipA with 1mM of lambda protein 
phosphatase, from BioLabs, overnight. The separation of the non-phosphorylated protein was 
also done with a Hiprep 26/10 desalting column. 
 
5.4.1.4. Protein cross linking studies 
For the cross linking experiments the proteins used were the phosphorylated HipA, the non-
phosphorylated HipA, HipB and the complex HipAB. The cross linker was added in excess to the 
protein samples. Two mg of BS3 were dissolved in water. After dissolving BS3 the solution was 
diluted into a final concentration of 100mM. For samples that had a protein concentration 
lower than 5mg/mL, a 20 to 50-fold molar excess of BS3 was used. The final concentrations of 
BS3 for the different proteins used were: 0mM (control), 0.50; 1.00; 2.00mM. This was 
performed to check which was the ideal concentration. Reactions were carried out at room 
temperature for 35 minutes. The reaction was stopped by adding 50mM Tris left to incubate 15 
minutes at room temperature. The 15 different protein samples were analysed by SDS-PAGE as 
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described in 4.4.1.1.1. Expressed proteins bands were cut and digested overnight with 0.1µg/µL 
trypsin as described in 4.4.1.1.2. without the point 4 because the samples were then analysed 
by mass spectrometry (LC-ESI-FT-ICR).  
 
1. LC-ESI-FT-ICR sample preparation 
LC-MS was performed according to Chesini (Chesini et al., 2011). The dried peptides were 
dissolved in 50µL of 0.1% formic acid. For the LC-MS experiments the buffer used was 0.1% of 
formic acid and were injected 5µL of each sample was analysed. Peptides were first separated 
on an Agilent 1200 chromatographic system (Agilent, Santa Clara, CA, USA) and on-line 
measured on a LTQ-FT Ultra mass spectrometer (Thermo Fisher Scientific, Wal-tham, MA, USA). 
The samples were first loaded and desalted on a (5mm x 0.3mm) Zorbax 300SB-C18 trapping 
column at a 4μl/min flow rate using a 2% (v/v) acetonitrile, 0.1% formic acid buffer, and then 
separated on a (150mm x 75μm) Zorbax 300SB-C18 analytical column (Agilent) by a 50min linear 
gradient ranging from 2% (v/v) to 80% (v/v) acetonitrile, 0.1% formic acid at a 0.3μl/min flow 
rate. The LC-effluent was directly coupled to a Triversa NanoMate ESI source (Advion, Ithaca, 
NY, USA), working in nano-LC mode and equipped with a D-chip whereon a 1.7kV voltage was 
supplied. During the LC-separation the FT-ICR mass analyser acquired MS scans at 100,000 
resolution, the 3 most intense precursor peptides for each MS scan were automatically selected 
and fragmented by the LTQ ion trap mass analyser. 
 
 Mass spectrometry analysis 
The MS and MS/MS data were used for research in Mascot Daemon, where the research was 
made using NCBI database. 
 
 pLink research  
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The pLink research was made using the MS/MS data and the protein sequence information, 
outputting the cross linked peptides in a pBuild software support and a spectrum identification 
from the MS/MS matching. 
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7. Attachments 
7.1. Expression of HipA/HipB 
- Carbenicillin (Cb) - Antibiotic 
C = 250mM 
m = 2.5g 
10mL MQ water 
- Use 40µL/100mL 
(save 2mL in eppendorfs at -20ºC) 
 
- IPTG (Isopropyl β-D-1-thiogalactopyranoside) 
m = 2,38g IPTG (freeze) 
10mL MQ water and dissolve 
 
1. Preculture  
LB Cb Proteins 
20mL 5µL 20µL or use from colonies (with a tip) 
40mL 10µL 40µL or use from colonies (with a tip) 
100mL 25µL 100mL or use from colonies (with a tip) 
200mL 50µL 20mL or use from colonies (with a tip) 
LB and Cb are in a dilution of (1:4)  
GROW OVER NIGHT at 37ºC (for maximum 60h!) 
 
2. Culture 
LB Cb Preculture 
 
IPTG (-20ºC) 
50mL 20µL 0,5mL 50µL 
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1L 400µL 10mL 1mL 
2L 800µL 20mL 2mL 
 
WAIT 3H measure OD (next step) and ADD IPTG (dilution of 1:100)! 
 
3. Optic Density at 600nm 
- Before adding IPTG: 
1mL around 0.6 for HipB and 0.7 for HipA 
- After adding IPTG: 
 
 
 
 
7.2. Protein Overexpression 
1. Samples Preparation for SDS-PAGE 
1mL is collected before adding IPTG and after adding IPTG, 1H/1H 
- Centrifuge samples for 5mins – separate pallet 
- Resuspend supernatant with MQ water: 
o A = 2,00 add 100µL 
o A = 1,00 add 50µL 
- Take 10µL from the sample and add 10µL loading buffer to the resuspended samples 
- Leave 5mins at 95ºC 
- 20µL sample and 15µL marker 
- Run gel for 45mins-1h30 
- Add Coomassie brilliant blue R-250, leave overnight 
-  Distain the gel with 30% methanol 
 
Time Quantity OD 
1H 1mL  
Should increase  
 
2H 1mL 
3H 1mL 
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2. In-gel digestion of proteins (from SDS-PAGE): 
- Always were gloves!! 
- Always keep solutions closed to prevent contamination of dust. 
 
Day 1 
a. Wash (rinse) the gel with water to remove dust particles 
b. Cut out the protein of interest and transfer it into an 1,5mL vial in small slashes (for a 
protein band use a scalpel, for a 2-PAGE protein spot use a spot picker) 
c. Wash the gel pieces by adding 150µL of 50% ACN/200mM ammonia bicarbonate to 
vial and incubate for 20min at 30ºC. Vortex and centrifuge ( to remove 
unpolymerized acrylamide and other contaminants, such as Coomassie, which may 
give a higher background during MS measurement) 
TIP: see the final volume that is needed and add for example: 1mL ACN and 1mL of ammonia 
bicarbonate (NH4HCO3) 
d. Do the wash step in c. until the coomassie dye has disappeared 
e. Dry gelpieces in speedvac (they will turn smaller and white) 
f. Add 10µL diluted trypsin (50 x dilution of stock = 0,1µg/µL trypsin in 50mM ammonia 
bicarbonate) 
TIP: first prepare the ammonia bicarbonate, for example, for a total volume of 2mL, use 250mL 
of 400mM with 1750 of MQ water. 
Dilute 1µL of trypsin (keep trypsin in ice) in 49µL of your 50mM ammonia bicarbonate 
g. Keep your solution on ice for 45mins 
h. Add 40µL of 50mM ammonia bicarbonate (gel pieces need to be submerged) 
i. Digestion overnight at 37ºC bath 
 
Day 2 
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a. Centrifuge the tube and transfer supernatants (solution containing peptides) to 
newly labeled 0,5mL vial 
b. Extract the peptides by adding 40µL of 60% ACN/0,1% HCOOH to the gel piece and 
incubate at 30ºC for 20min (the amount can be increased if the gel piece isn’t 
entirely covered in liquid) 
TIP: For a final volume of 1mL pipe 600µL of ACN and 400µL of HCOOH 
c. Vortex for 3min, centrifuge and combine the supernatant to the corresponding 
0,5mL vial (which already contains peptides) 
d. Repeat the extraction step, by adding 20µL of 60% ACN/0,1%HCOOH 
e. Dry the peptide solution in the speedvac 
f. Dissolve the peptides in 10µL of 0,1% HCOOH (if you will not analyse the peptides 
immediately, better not dissolve them before storing at -20ºC) 
 
3. Preparing the matrix: 
a. Always set the correct matrix in the acquisition method (α-cyano, DHB) 
b. 5mg/mL matrix, 50% ACN, 0,1% TFA 
TIP: Total volume – 1mL which is 1000µL so is 500µL of ACN, 1µL of TFA and 499µL of MQ water 
If sample doesn’t dry fast enough (this will lead to bad crystallization) use 70% ACN. 
 
7.3. Purification of HipA/HipB 
1. Immobilized Metal Affinity Chromatography 
Buffer 1 (500mL) at pH = 7.5: 
25mM Na2HPO4  
Mw = 141.96g/mol 
m = 3.54g 
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500mM NaCl  
 Mw = 58.443g/mol 
 m = 29.2215g 
Buffer 2 (200mL) at pH = 7.5: 
25mM Na2HPO4  
Mw = 141.96g/mol 
 m = 3.549g 
500mM NaCl  
 Mw = 58.443g/mol 
 m = 29.2215g 
500mM Imidazole 
 Mw = 68.077g/mol 
 m = 6.80775g 
 
7.4. Cross linking studies 
Samples 
Protein 
Quantity 
Cross Linker (25mM) Tris 
(1M) 0.5mM 1mM 2mM 
Phosphorylated HipA 50µL 1µL 2µL 4µL 50µL 
Non-phosphorylated HipA 50µL 1µL 2µL 4µL 50µL 
HipB 50µL 1µL 2µL 4µL 50µL 
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HipAB 50µL 1µL 2µL 4µL 50µL 
 
- BS3 preparation: 
Dissolve 2mg in 140µL of water  
- Gel preparation: 
25µL of sample + 10µL loading buffer 
 
